FDA to evaluate children’s cough medicine containing opioids
A federal committee will meet in three weeks to consider whether cough medicine containing certain opioids should be prescribed to children, the Food and Drug Administration announced Monday.
The agency already warned in April that drugs containing codeine, which is an opiate, “should not be used to treat pain or cough” in children under 12. The warning must appear on those drugs’ labels. At the time, the agency said that codeine, along with tramadol, an opioid found in some pain medications for children, “carry serious risks, including slowed or difficult breathing and death, which appear to be a greater risk in children younger than 12 years.”